Mutations of epidermal growth factor receptor in colon cancer indicate susceptibility or resistance to gefitinib

  • Authors:
    • Xiang Zhang
    • Hisashi Nagahara
    • Koshi Mimori
    • Hiroshi Inoue
    • Tetsuji Sawada
    • Masaichi Ohira
    • Kosei Hirakawa
    • Masaki Mori
  • View Affiliations

  • Published online on: June 1, 2008     https://doi.org/10.3892/or.19.6.1541
  • Pages: 1541-1544
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Somatic mutations of the epidermal growth factor receptor (EGFR) gene may predict the sensitivity of non-small cell lung cancers to gefitinib. In our previous study, we identified somatic mutations in the tyrosine kinase domain of the EGFR gene in 12.1% of colon cancer cases. Herein, we focus on whether the mutations are associated with the sensitivity of colon cancer to gefitinib. The E749K mutation in exon 19 and E762G and A767T mutations in exon 20 were introduced into the full-length EGFR coding sequence in a pBKCMV-hEGFR vector by site-directed mutagenesis and transfected into LS174T cells. The sensitivity to gefitinib was compared between the transfected LS174T and the parental cells by a cytotoxic assay. The LS174T cells with E749K were significantly (p<0.05) more responsive to gefitinib than the parental cells. On the other hand, LS174T cells with E762G or A767T were significantly (p<0.05) more resistant than the parental cells. In conclusion, detection of somatic mutations in the epidermal growth factor receptor may play an important role in predicting sensitivity to gefitinib in colon cancer.

Related Articles

Journal Cover

June 2008
Volume 19 Issue 6

Print ISSN: 1021-335X
Online ISSN:1791-2431

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Zhang X, Nagahara H, Mimori K, Inoue H, Sawada T, Ohira M, Hirakawa K and Mori M: Mutations of epidermal growth factor receptor in colon cancer indicate susceptibility or resistance to gefitinib. Oncol Rep 19: 1541-1544, 2008
APA
Zhang, X., Nagahara, H., Mimori, K., Inoue, H., Sawada, T., Ohira, M. ... Mori, M. (2008). Mutations of epidermal growth factor receptor in colon cancer indicate susceptibility or resistance to gefitinib. Oncology Reports, 19, 1541-1544. https://doi.org/10.3892/or.19.6.1541
MLA
Zhang, X., Nagahara, H., Mimori, K., Inoue, H., Sawada, T., Ohira, M., Hirakawa, K., Mori, M."Mutations of epidermal growth factor receptor in colon cancer indicate susceptibility or resistance to gefitinib". Oncology Reports 19.6 (2008): 1541-1544.
Chicago
Zhang, X., Nagahara, H., Mimori, K., Inoue, H., Sawada, T., Ohira, M., Hirakawa, K., Mori, M."Mutations of epidermal growth factor receptor in colon cancer indicate susceptibility or resistance to gefitinib". Oncology Reports 19, no. 6 (2008): 1541-1544. https://doi.org/10.3892/or.19.6.1541